Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyroglobulin and antithyroglobulin antibody

Deshan Zhao
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1655;
Deshan Zhao
1The Department of Nuclear Medicine, The second hospital of shanxi medical university, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1655

Objectives To explore the values of preoperative serum TSH,Tg,TgAb and TSH/Tg in predicting the risk of differentiated thyroid carcinoma.

Methods 122 patients with thyroid nodules who got operations were studied, Of all, 55 patients with differentiated thyroid carcinoma (54 papillary and 1 follicular),67 cases with benign thyroid nodules(40 nodular goiter and 27 adenoma). TSH and Tg were measured by chemiluminescence method,and TgAb by radioimmunoassay.The postoperative pathological results was regard as the gold standard of diagnosing thyroid cancer.

Results 1. Preoperative serum Tg levels in thyroid cancer group(24.09±64.59) and benign thyroid nodules group (23.37±112.14)had no statistical differences (Z=1.092,P>0.05).TSH levels in thyroid carcinoma group (2.32±2.28) were higher than that in benign thyroid nodules group (1.75±1.22), (Z=2.107,P<0.05).The positive rate of Tg combined with TgAb in thyroid cancer group (72.7%) was higher than that in benign thyroid nodules group(55.2%) (χ2=3.975,P<0.05). 2.Receiver operating characteristic (ROC) curves showing sensitivity as a function of specificity were calculated for TSH,Tg levels and TSH/Tg values to evaluate the potential accuracy of the three index as predicting differentiated thyroid carcinoma.The area under the curve (AUC) of TSH was 0.611, 95% confidence interval (95% CI) for (0.509~0.713),P<0.05.The optimum threshold in ROC curves of TSH was 2.31mIU/L. The sensitivity and specificity of TSH were 71.6% and 50.9% respectively.The AUC of TSH: Tg values was 0.617, 95% CI (0.518 ~ 0.716),P<0.05.The best critical value of TSH/Tg was 0.11 IU/mg. The sensitivity and specificity of TSH/Tg were 61.2% and 50.9% respectively.The AUC of Tg was less than 0.5.

Conclusions 1.Serum Tg elevated abnormally is not an independent predicting factor of differentiated thyroid cancer. 2.The elevated Tg levels and/or positive TgAb and TSH/Tg>0.11IU/mg can be used as effective supplementary means of ultrasound examination in predicting differentiated thyroid carcinoma.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyroglobulin and antithyroglobulin antibody
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyroglobulin and antithyroglobulin antibody
Deshan Zhao
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1655;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyroglobulin and antithyroglobulin antibody
Deshan Zhao
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1655;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Multimodality imaging in calcific uremic arteriolopathy
  • Parathyroid Imaging: Emerging role of 18F-fluorocholine Positron Emission Tomography and Future Directions
  • Renal scintigraphy following kidney transplantation – ATN, Rejection, and More
Show more General Clinical Specialties

MTA II: Endocrinology/Neuroendocrine Posters

  • A PET study of burn-induced tissue-specific insulin resistance
  • Effects of hyperglycemia on FDG biodistribution in a large oncology clinical practice
  • Robustness of Male Treatment Failure with I-131 in Hyperthyroidism
Show more MTA II: Endocrinology/Neuroendocrine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire